Ep 237 – Using Genomics to Drive Personalized, Preventive Medicine with Brian Cornblatt, Director of Personalized & Precision Medicine

What if we could reverse the symptoms of autism within the first year of diagnosis?

How about prevent new cancer diagnoses from becoming metastatic?

Or determine in infancy what medications a person can or cannot safely take?

This is the promise of personalized medicine, and it could be the basis of preventive medicine, but so far, it is not a model that has been realized, at least within the US. But our guest today, Dr. Brian Cornblatt, has successfully done all of these things at his clinic by uncovering the genetic vulnerabilities that lead to dysfunction in the body. Their approach centers around repairing, rebuilding, and restoring function, not just treating symptoms. It’s revolutionary, and it’s also well within our reach scientifically, IF we could get insurance companies to pay for it.

Dr. Brian Cornblatt is the Clinic Director and Director of Personalized & Precision Medicine, and Chief Scientific & Research Officer for Quantum Executive Health Optimization Clinic. Dr. Cornblatt focusses on uncovering genetic vulnerabilities to detect root causes of dysfunction and helps the treatment teams develop personalized plans for each client to promote true health. Dr. Cornblatt is also Chief Medical Officer of AION Biosystems, cofounder and Chief Scientific Officer of International Nutrition Associates (INA) and Integrative Health Solutions (IHS). INA provides clinical trial-backed nutraceuticals to countries throughout Asia and South America as well as novel and high-quality raw materials globally while IHS provides global distribution services for nutraceuticals. Dr. Cornblatt serves as a Board Member for the Johns Hopkins Colorectal Cancer Center of Excellence, Microbiome Alliance for Disease Prevention, and Longevity AI.